Home LiteratureArticle Details
PMID: 20357768 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Caspase activation precedes and leads to tangles.

Nature ·Vol. 464 ·No. 7292 ·2010-04-22 ·Pages 1201-4

de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, Hyman BT

Abstract

Studies of post-mortem tissue have shown that the location of fibrillar tau deposits, called neurofibrillary tangles (NFT), matches closely with regions of massive neuronal death, severe cytological abnormalities, and markers of caspase activation and apoptosis, leading to the idea that tangles cause neurodegeneration in Alzheimer's disease and tau-related frontotemporal dementia. However, using in vivo multiphoton imaging to observe tangles and activation of executioner caspases in living tau transgenic mice (Tg4510 strain), we find the opposite: caspase activation occurs first, and precedes tangle formation by hours to days. New tangles form within a day. After a new tangle forms, the neuron remains alive and caspase activity seems to be suppressed. Similarly, introduction of wild-type 4-repeat tau (tau-4R) into wild-type animals triggered caspase activation, tau truncation and tau aggregation. Adeno-associated virus-mediated expression of a construct mimicking caspase-cleaved tau into wild-type mice led to the appearance of intracellular aggregates, tangle-related conformational- and phospho-epitopes, and the recruitment of full-length endogenous tau to the aggregates. On the basis of these data, we propose a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles. Because tangle-bearing neurons are long-lived, we suggest that tangles are 'off pathway' to acute neuronal death. Soluble tau species, rather than fibrillar tau, may be the critical toxic moiety underlying neurodegeneration.

MeSH Terms
Animals Brain/metabolism,pathology Caspases/metabolism Cell Death Enzyme Activation Humans Mice Mice, Transgenic Neurofibrillary Tangles/chemistry,enzymology,metabolism,pathology Neurons/enzymology,metabolism,pathology Protein Processing, Post-Translational Solubility Time Factors tau Proteins/chemistry,genetics,metabolism
Chemicals
tau Proteins Caspases
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
de Calignon Alix
MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Alzheimer's Disease Research Laboratory, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
Fox Leora M
Pitstick Rose
Carlson George A
Bacskai Brian J
Spires-Jones Tara L
Hyman Bradley T
References (29)
29 references, click to expand
  1. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.
    Ann Neurol. 1997 Jan;41(1):17-24 PMID: 9005861
  2. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.
    J Neurochem. 2006 May;97(4):1005-14 PMID: 16606369
  3. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10032-7 PMID: 12888622
  4. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.
    J Histochem Cytochem. 2000 Sep;48(9):1223-32 PMID: 10950879
  5. Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease.
    J Neuropathol Exp Neurol. 2008 May;67(5):470-83 PMID: 18431250
  6. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene].
    FEBS Lett. 2008 Mar 19;582(6):901-6 PMID: 18291106
  7. AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice.
    PLoS One. 2009 Oct 01;4(10):e7280 PMID: 19794916
  8. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
    Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5547-51 PMID: 1319065
  9. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.
    J Clin Invest. 2004 Jul;114(1):121-30 PMID: 15232619
  10. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Am J Pathol. 2004 Aug;165(2):523-31 PMID: 15277226
  11. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
    J Neurosci. 2004 Sep 8;24(36):7895-902 PMID: 15356202
  12. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy.
    Am J Pathol. 2008 Jan;172(1):123-31 PMID: 18079436
  13. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Acta Neuropathol. 2002 Jan;103(1):26-35 PMID: 11837744
  14. Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy.
    J Neuropathol Exp Neurol. 2009 Jul;68(7):757-61 PMID: 19535996
  15. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    J Neurochem. 2003 Aug;86(3):582-90 PMID: 12859672
  16. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Acta Neuropathol. 2009 Jun;117(6):687-97 PMID: 19190923
  17. Tau suppression in a neurodegenerative mouse model improves memory function.
    Science. 2005 Jul 15;309(5733):476-81 PMID: 16020737
  18. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
    J Neurosci. 2008 Jan 16;28(3):737-48 PMID: 18199773
  19. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
    Neurobiol Aging. 2005 Jul;26(7):1015-22 PMID: 15748781
  20. Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons.
    Neuroscience. 2007 Jan 5;144(1):119-27 PMID: 17055174
  21. C-terminal truncation modulates both nucleation and extension phases of tau fibrillization.
    FEBS Lett. 2006 Jan 9;580(1):211-5 PMID: 16364303
  22. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons.
    J Neurosci. 2008 Jan 23;28(4):862-7 PMID: 18216194
  23. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy.
    Am J Pathol. 2006 May;168(5):1598-607 PMID: 16651626
  24. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
    J Neurosci. 2005 Nov 16;25(46):10637-47 PMID: 16291936
  25. Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation.
    J Biol Chem. 2006 Jul 14;281(28):19107-14 PMID: 16687396
  26. Apoptosis in transgenic mice expressing the P301L mutated form of human tau.
    Mol Med. 2008 May-Jun;14(5-6):309-17 PMID: 18368144
  27. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.
    Am J Pathol. 2001 Jan;158(1):189-98 PMID: 11141492
  28. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing.
    Hum Mol Genet. 2009 Nov 1;18(21):4153-70 PMID: 19654187
  29. Control of memory formation through regulated expression of a CaMKII transgene.
    Science. 1996 Dec 6;274(5293):1678-83 PMID: 8939850
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2010-04-22
Epub
2010-00-31
Pages
1201-4
Language
English
Region
England
NLM ID
0410462
PMCID
PMC3091360
Subset
IM
Grants
NIA NIH HHS · K99 AG033670-01A1 · United States
NIA NIH HHS · R01 AG008487-18 · United States
NIA NIH HHS · P30 AG062421 · United States
NIA NIH HHS · R01 AG008487 · United States
NIA NIH HHS · P50 AG005134 · United States
NIA NIH HHS · K99 AG033670 · United States
NIA NIH HHS · R01 AG026249 · United States
NIA NIH HHS · AG 026249 · United States
NIA NIH HHS · R01 AG026249-01 · United States
NIA NIH HHS · AG08487 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com